Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.14
+0.62 (9.51%)
At close: Mar 9, 2026, 4:00 PM EDT
7.27
+0.13 (1.82%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Edesa Biotech Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2020 - 2017
Net Income
-7.82-7.19-6.17-8.37-17.55-13.34
Upgrade
Depreciation & Amortization
0.10.120.190.180.120.12
Upgrade
Stock-Based Compensation
1.050.730.541.252.263.2
Upgrade
Other Operating Activities
---0.01---
Upgrade
Change in Accounts Receivable
-0.06-0.380.360.562.03-3.23
Upgrade
Change in Accounts Payable
-1.07-0.720.02-0.560.88-0.12
Upgrade
Change in Other Net Operating Assets
-0.090.110.20.3-0.02-0.28
Upgrade
Operating Cash Flow
-7.89-7.32-4.89-6.64-12.28-13.66
Upgrade
Capital Expenditures
-----0.01-0.01
Upgrade
Investing Cash Flow
-----0.01-0.01
Upgrade
Long-Term Debt Repaid
---0.03---
Upgrade
Net Debt Issued (Repaid)
---0.03---
Upgrade
Issuance of Common Stock
10.597.720.735.1211.9614.36
Upgrade
Other Financing Activities
-0.61-0.57-0.11-0.29-0.33-0.19
Upgrade
Financing Cash Flow
18.3117.030.594.8311.6314.17
Upgrade
Foreign Exchange Rate Adjustments
0.070.05-0.030.08-0.090.12
Upgrade
Net Cash Flow
10.499.75-4.32-1.73-0.750.63
Upgrade
Free Cash Flow
-7.89-7.32-4.89-6.64-12.28-13.67
Upgrade
Free Cash Flow Per Share
-1.16-1.29-1.53-2.32-5.86-7.92
Upgrade
Levered Free Cash Flow
-5.37-4.91-3.16-3.78-6.12-14.93
Upgrade
Unlevered Free Cash Flow
-5.37-4.91-3.16-3.78-6.12-14.93
Upgrade
Change in Working Capital
-1.23-0.990.570.312.89-3.64
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.